BMO Capital Markets Forecasts Strong Price Appreciation for Extendicare (TSE:EXE) Stock

Extendicare (TSE:EXE) had its price target upped by equities research analysts at BMO Capital Markets from C$11.00 to C$13.50 in a research note issued to investors on Monday,BayStreet.CA reports. BMO Capital Markets’ price target points to a potential upside of 7.48% from the company’s previous close.

A number of other equities research analysts also recently issued reports on EXE. Cormark raised Extendicare to a “moderate buy” rating in a research report on Wednesday, February 19th. TD Securities increased their price target on Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research report on Thursday, November 14th. Finally, Royal Bank of Canada increased their price target on Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 28th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of C$11.50.

Extendicare Stock Performance

Shares of Extendicare stock traded up C$0.15 on Monday, hitting C$12.56. The stock had a trading volume of 213,355 shares, compared to its average volume of 172,766. Extendicare has a twelve month low of C$6.63 and a twelve month high of C$12.93. The business’s 50 day moving average is C$10.69 and its two-hundred day moving average is C$9.76. The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. The stock has a market cap of C$1.05 billion, a price-to-earnings ratio of 16.01 and a beta of 1.26.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.